Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Aadi Bioscience, Inc. (ARPO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Sold 25,569 shares @ $4.3685, valued at $111.7k
Sold 16,431 shares @ $4.0961, valued at $67.3k
10/03/2023 4 Lennon David James (CEO) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Granted 32,558 restricted stock units @ $0
Granted 490,000 options to buy @ $0
10/03/2023 3 Lennon David James (CEO) has filed a Form 3 on Aadi Bioscience, Inc.
10/02/2023 8-K Quarterly results
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update"
08/03/2023 4 Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Sold 22,710 shares @ $5.219, valued at $118.5k
Sold 19,290 shares @ $5.197, valued at $100.3k
07/06/2023 4 Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Sold 10,000 shares @ $6.6446, valued at $66.4k
Sold 16,171 shares @ $6.5471, valued at $105.9k
Sold 15,829 shares @ $6.2716, valued at $99.3k
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/06/2023 4 Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Sold 7,260 shares @ $8.1891, valued at $59.5k
06/05/2023 4 Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Sold 4,982 shares @ $7.9222, valued at $39.5k
Sold 12,443 shares @ $7.9901, valued at $99.4k
Sold 17,315 shares @ $8.1096, valued at $140.4k
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial"
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2023 4 Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Sold 24,479 shares @ $7.7983, valued at $190.9k
Sold 7,521 shares @ $7.4757, valued at $56.2k
Sold 7,695 shares @ $7.6768, valued at $59.1k
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/05/2023 4 Desai Neil (Executive Chairman) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Sold 9,583 shares @ $7.446, valued at $71.4k
Sold 12,869 shares @ $7.3029, valued at $94k
Sold 7,336 shares @ $7.235, valued at $53.1k
04/04/2023 4 Giacobello Scott M. (CFO, Interim CEO & President) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Granted 100,000 options to buy @ $7.47, valued at $747k
04/03/2023 144 Form 144 - Report of proposed sale of securities:
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/29/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/28/2023 8-K/A Quarterly results
03/28/2023 8-K Quarterly results
03/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Aadi Bioscience Announces Leadership Transition"
03/02/2023 4 ITRI LORETTTA M (Chief Medical Officer) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Granted 102,350 options to buy @ $10.93, valued at $1.1M
03/02/2023 4 Giacobello Scott M. (CFO) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Granted 90,000 options to buy @ $10.93, valued at $983.7k
03/02/2023 4 Delaney Brendan (See remarks) has filed a Form 4 on Aadi Bioscience, Inc.
Txns: Granted 235,000 options to buy @ $10.93, valued at $2.6M
02/10/2023 SC 13G/A Satter Muneer A reports a 6.7% stake in Aadi Bioscience, Inc.
01/23/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
01/17/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy